Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag

被引:76
作者
Backer, Marina V. [1 ]
Patel, Vimal
Jehning, Brian T.
Claffey, Kevin P.
Backer, Joseph M.
机构
[1] SibTech Inc, Newington, CT 06111 USA
[2] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA
关键词
site-specific conjugation; immobilization; growth factors; VEGF; tissue engineering;
D O I
10.1016/j.biomaterials.2006.06.025
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Developing tissue engineering scaffolds with immobilized growth factors requires facile and reliable methods for the covalent attachment of functionally active proteins. We describe here a new approach to immobilize recombinant proteins based on expression of the protein of interest with a 15-aa long fusion tag (Cys-tag), which avails a free sulfhydryl group for site-specific conjugation. To validate this approach, we conjugated a single-chain vascular endothelial growth factor expressed with an N-terminal Cys-tag (scVEGF) to fibronectin (FN) using a common thiol-directed bi-functional cross-linking agent. We found that the FN-scVEGF conjugate retains VEGF activity similar to that of free scVEGF when used as a soluble ligand. Cells expressing VEGF receptor VEGFR-2 grown on plates coated with FN-scVEGF displayed morphological phenotypes similar to those observed for cells grown on FN in the presence of equivalent amounts of free scVEGF. In addition, 293/KDR cell growth stimulation was observed in the same concentration range with either immobilized or free scVEGF. The effects of immobilized scVEGF, and soluble scVEGF were blocked by NVP-AAD777-NX, a VEGF receptor tyrosine kinase inhibitor. These data indicate that site-specific immobilization via Cys-tag provides a facile and reliable method for permanent deposition of functionally active growth factors on synthetic or protein scaffolds with applications for advanced tissue engineering. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5452 / 5458
页数:7
相关论文
共 30 条
[1]   Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature [J].
Backer, MV ;
Gaynutdinov, TI ;
Patel, V ;
Bandyopadhyaya, AK ;
Thirumamagal, BTS ;
Tjarks, W ;
Barth, RF ;
Claffey, K ;
Backer, JM .
MOLECULAR CANCER THERAPEUTICS, 2005, 4 (09) :1423-1429
[2]   Adapter protein for site-specific conjugation of payloads for targeted drug delivery [J].
Backer, MV ;
Gaynutdinov, TI ;
Patel, V ;
Jehning, BT ;
Myshkin, E ;
Backer, JM .
BIOCONJUGATE CHEMISTRY, 2004, 15 (05) :1021-1029
[3]   Humanized docking system for assembly of targeting drug delivery complexes [J].
Backer, MV ;
Gaynutdinov, TI ;
Gorshkova, II ;
Crouch, RJ ;
Hu, T ;
Aloise, R ;
Arab, M ;
Przekop, K ;
Backer, JA .
JOURNAL OF CONTROLLED RELEASE, 2003, 89 (03) :499-511
[4]   Functionally active VEGF fusion proteins [J].
Backer, MV ;
Backer, JM .
PROTEIN EXPRESSION AND PURIFICATION, 2001, 23 (01) :1-7
[5]  
BACKER MV, 2006, DOCK LOCK SYSTEM LIN, DOI DOI 10.1021/BC060037U
[6]  
Bentz H, 1998, J BIOMED MATER RES, V39, P539, DOI 10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO
[7]  
2-K
[8]   In vivo tumor angiogenesis imaging with site-specific labeled 99mTc-HYNIC-VEGF [J].
Blankenberg, Francis G. ;
Backer, Marina V. ;
Levashova, Zoia ;
Patel, Vimalkumar ;
Backer, Joseph M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 (07) :841-848
[9]   Biocompatibility of NGF-grafted GTG membranes for peripheral nerve repair using cultured Schwann cells [J].
Chen, PR ;
Ming, MH ;
Sun, JS ;
Chen, MH ;
Tsai, CC ;
Lin, FH .
BIOMATERIALS, 2004, 25 (25) :5667-5673
[10]   The ideal small arterial substitute: a search for the Holy Grail? [J].
Conte, MS .
FASEB JOURNAL, 1998, 12 (01) :43-45